These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2122616)

  • 41. Reversibility of neuropathology in Tay-Sachs-related diseases.
    Cachón-González MB; Wang SZ; Ziegler R; Cheng SH; Cox TM
    Hum Mol Genet; 2014 Feb; 23(3):730-48. PubMed ID: 24057669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.
    Maegawa GH; Stockley T; Tropak M; Banwell B; Blaser S; Kok F; Giugliani R; Mahuran D; Clarke JT
    Pediatrics; 2006 Nov; 118(5):e1550-62. PubMed ID: 17015493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Gangliosidosis GM2 type 2 (Sandhoff disease)].
    Sánchez-Corona J; Vaca G; González-Flores SA; Villar V; Solé MT; Barajas LO; Velázquez R; Valdez-Luviano J; Cantú JM
    Rev Invest Clin; 1985; 37(1):43-7. PubMed ID: 4001618
    [No Abstract]   [Full Text] [Related]  

  • 44. Ganglioside storage diseases: an updated review.
    O'Brien JS
    Ital J Neurol Sci; 1981 Aug; 2(3):219-26. PubMed ID: 6804413
    [No Abstract]   [Full Text] [Related]  

  • 45. Sandhoff's disease (type II GM2 gangliosidosis). Clinical, biochemical and ultrastructural study of a case.
    Pallini R; Berardi R; Cioni M; d'Ettorre M; De Crecchio G; Gerli R; Minervino M; Sammartino A; Federico A
    Metab Pediatr Syst Ophthalmol (1985); 1985; 8(2-3):49-52. PubMed ID: 2967418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
    Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.
    Conzelmann E; Kytzia HJ; Navon R; Sandhoff K
    Am J Hum Genet; 1983 Sep; 35(5):900-13. PubMed ID: 6614006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Recent advances in molecular genetics of GM2 gangliosidosis].
    Wakamatsu N
    Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GM2-gangliosidosis. Clinical and biochemical aspects of four cases.
    Praamstra P; Wevers RA; Gabreëls FJ; Rotteveel JJ; Renier WO; Sengers RC; Lamers KJ
    Clin Neurol Neurosurg; 1990; 92(2):143-8. PubMed ID: 2163796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.
    Johnson WG; Cohen CS; Miranda AF; Waran SP; Chutorian AM
    Am J Hum Genet; 1980 Jul; 32(4):508-18. PubMed ID: 6772023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GM2-gangliosidosis, AB variant: clinico-pathological study of a case.
    de Baecque CM; Suzuki K; Rapin I; Johnson AB; Whethers DL
    Acta Neuropathol; 1975 Dec; 33(3):207-26. PubMed ID: 174379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetics and Therapies for GM2 Gangliosidosis.
    Cachon-Gonzalez MB; Zaccariotto E; Cox TM
    Curr Gene Ther; 2018; 18(2):68-89. PubMed ID: 29618308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultrastructure of the conjunctiva, skin, and gingiva: a case of Sandhoff's disease in a Jewish patient.
    Messer G; Harel S; Erlich B; Navon R; Nemet P; Sarnat H; Shomrat R; Legum C
    Arch Pathol Lab Med; 1980 Mar; 104(3):123-9. PubMed ID: 6243915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Adult form of GM2-gangliosidosis: a man and 2 sisters with hexosaminidase-A and -B deficiency (Sandhoff disease) and literature review].
    Schnorf H; Bosshard NU; Gitzelmann R; Spycher MA; Isler P; Waespe W
    Schweiz Med Wochenschr; 1996 May; 126(18):757-64. PubMed ID: 8693300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biomedical genetics of the inherited metabolic diseases: the GM2-gangliosidoses.
    Kolodny EH
    Am J Ment Defic; 1984 Mar; 88(5):582-9. PubMed ID: 6428229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Reconstruction of hexosaminidase isoenzymes during hybridization of fibroblasts from Tay-Sachs and Sandhoff diseases].
    Beĭer EM; Vidershaĭn GIa; Venert M
    Biull Eksp Biol Med; 1984 Jan; 97(1):83-6. PubMed ID: 6229294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns of complex carbohydrate storage in four lysosomal storage diseases: fucosidosis, GM1-gangliosidosis, GM2-gangliosidosis (Sandhoff variant) and mannosidosis.
    Dawson G; Chen Tsay G
    Biochem Exp Biol; 1977; 13(1):15-25. PubMed ID: 418790
    [No Abstract]   [Full Text] [Related]  

  • 58. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.
    Inui K; Wenger DA
    Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study.
    Nestrasil I; Ahmed A; Utz JM; Rudser K; Whitley CB; Jarnes-Utz JR
    Mol Genet Metab; 2018 Feb; 123(2):97-104. PubMed ID: 29352662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sandhoff's disease (GM2 gangliosidosis type 2). Histopathology and ultrastructure of the eye.
    Brownstein S; Carpenter S; Polomeno RC; Little JM
    Arch Ophthalmol; 1980 Jun; 98(6):1089-97. PubMed ID: 7387515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.